Alzheimer's disease (AD) is a neurodegenerative disease characterized by memory loss and cognitive impairment. &#
x3b2;-amyloid (A&#
x3b2;) is one of the typical pathological features of AD, and its accumulation leads to neuronal death from oxidative stress. Here, we found that hederagenin (HG), a natural product, exhibits anti-tumor, anti-inflammatory, anti-depressant, anti-neurodegenerative biological activities. However, whether HG has anti-A&#
x3b2; activity remains unclear. Based on the characteristics of HG, it is hypothesized that HG has biological activity against A&#
x3b2; injury. Therefore, A&#
x3b2;-injured SH-SY5Y cells were constructed, and the protective effect of HG against A&#
x3b2; injury was further evaluated using C. elegans. The results showed that HG increased superoxide dismutase activity, effectively reduced A&#
x3b2;-induced oxidative damage, and reduced apoptosis via the PI3&#
x2005;K/Akt signaling pathway. HG inhibited A&#
x3b2; deposition and delayed senescence and paralysis in the C. elegans strain, CL4176. HG showed inhibitory effects on A&#
x3b2;; therefore, more natural active products are expected to be applied in AD therapy.